Since BC is considered a highly heterogeneous disease, it is usually classified in five intrinsic molecular subtypes (Luminal A, Luminal B, HER2-enriched, Basal-like, and Normal-like), determined by profiling mRNA expression of at least 50 genes (PAM50). The gene discussed is ERBB2; the disease is breast cancer.